<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03020264</url>
  </required_header>
  <id_info>
    <org_study_id>RC16_0351</org_study_id>
    <nct_id>NCT03020264</nct_id>
  </id_info>
  <brief_title>Frequency of Hypoglycemia in Patients With Type 2 Diabetes Under Insulin Therapy Older Than 75 Years in Real Life</brief_title>
  <acronym>HYPOAGE</acronym>
  <official_title>Frequency of Hypoglycemia in Patients With Type 2 Diabetes Under Insulin Therapy Older Than 75 Years in Real Life</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Nantes University Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Nantes University Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Diabetes is a chronic and progressive disease that affects nearly 3.5 million people in
      France.

      Currently the investigators are seeing an aging of the population explained by the increase
      in life expectancy and thus an increasing incidence of diabetes in the elderly. However, the
      frequency of hypoglycemia in older vulnerable patients remains poorly characterized
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">November 28, 2017</start_date>
  <completion_date type="Anticipated">December 2018</completion_date>
  <primary_completion_date type="Anticipated">December 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Other</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Number of confirmed or severe hypoglycemia</measure>
    <time_frame>1 month</time_frame>
    <description>Percentage of patients with at least one episode of confirmed and / or severe hypoglycaemia by measuring capillary blood glucose during 4 weeks of prospective follow-up.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>number of events / patient / month of severe hypoglycemia</measure>
    <time_frame>1 month</time_frame>
    <description>Number of confirmed severe hypoglycaemia episodes (events / patient / month), symptomatic or asymptomatic, occurring in patients during 4 weeks of prospective follow-up.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of hospitalizations due to hypoglycemia</measure>
    <time_frame>1 month</time_frame>
    <description>Number and duration of hospital stays</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of asymptomatic confirmed (blood glucose value &lt;0.70g / L) hypoglycemia</measure>
    <time_frame>1 month</time_frame>
    <description>Confirmed asymptomatic hypoglycaemia (events / patient / month) occurring in patients collected with the FREESTYLE Libre glucose sensor</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of hypoglycaemia in elderly patients admitted to EHPAD</measure>
    <time_frame>1 month</time_frame>
    <description>Confirmed hypoglycaemia (events / patient / month), symptomatic or asymptomatic, occurring in patients hospitalized in long-term geriatric care sector.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of confirmed nocturnal hypoglycaemia (occurring between 0h00-6h00)</measure>
    <time_frame>1 month</time_frame>
    <description>Confirmed nocturnal hypoglycaemia (events / patient / month), symptomatic or asymptomatic, occurring in patients</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of confirmed hypoglycaemia with a threshold blood glucose value &lt;0.54g / L (neuroglucopenic threshold)</measure>
    <time_frame>1 month</time_frame>
    <description>Confirmed neuroglucopenic hypoglycaemia (events / patient / month), symptomatic or asymptomatic, occurring in patients</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of pseudo-hypoglycaemia and unconfirmed hypoglycaemia (Symptoms consistent with hypoglycemia, but with a blood glucose value ≥ 70 mg / dL)</measure>
    <time_frame>1 month</time_frame>
    <description>Confirmed pseudo-hypoglycaemia and unconfirmed hypoglycaemia (events / patient / month), occurring in patients</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Score for fear of hypoglycemia in elderly diabetic patients</measure>
    <time_frame>1 month</time_frame>
    <description>Score for fear of hypoglycaemia (HFS-II)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of confirmed and severe hypoglycaemia in patients with type 2 diabetes aged 75 years and older in &quot;vigorous&quot; and &quot;vulnerable&quot; subgroups of patients according to a geriatric assessment score</measure>
    <time_frame>1 month</time_frame>
    <description>Confirmed hypoglycaemia (events / patient / month), symptomatic or asymptomatic, occurring in patients</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of the transition to ER due to hypoglycemia</measure>
    <time_frame>1 month</time_frame>
    <description>Number and duration of emergency stays</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of falls due to hypoglycemia</measure>
    <time_frame>1 month</time_frame>
    <description>Number of falls and loss of autonomy (no home support)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of death due to hypoglycemia</measure>
    <time_frame>1 month</time_frame>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">250</enrollment>
  <condition>Type2 Diabetes</condition>
  <condition>Elderly</condition>
  <condition>Hypoglycemia</condition>
  <arm_group>
    <arm_group_label>Patients older than 75 years</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Collection of hypoglycaemia épisodes with the glycemic sensor FREESTYLE Libre</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>glycemic sensor FREESTYLE Libre</intervention_name>
    <description>Collection of hypoglycemia episodes with glycemic sensor FREESTYLE Libre</description>
    <arm_group_label>Patients older than 75 years</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Male or female ≥ 75 years of age;

          -  Type 2 diabetes for at least 1 year and treated with insulin for at least 6 months;

          -  Treated with basal insulin (ie glargine U100: Lantus®, Abasaglar®, glargine U300:
             Toujeo®, detemir: levemir®, NPH), premix (ie Novomix® and Humalog Mix®), and / Insulin
             associated or not with one or more oral and / or injectable antidiabetic agents
             (analog of GLP1...);

          -  Benefiting from at least 1 capillary glucose per day (carried out by the patient
             himself or a caregiver);

          -  Benefiting from a standardized geriatric assessment;

          -  Signature of informed consent.

        Exclusion Criteria:

          -  Male or female aged &lt;75 years;

          -  Person without diabetes or type 1 diabetes;

          -  Patient treated only lifestyle modifications and / or oral anti-diabetic drugs and /
             or GLP-1 receptor agonists alone;

          -  Subjects with secondary or corticosteroid-induced diabetes;

          -  Refusal to participate in the study or inability to collect consent;

          -  Patient for whom follow-up of the study procedures is impossible (glycemic record
             impossible or insufficient);

          -  Patient not eligible for geriatric assessment;

          -  Patient already participating in another study;

          -  Patient with a severe pathology limiting his life expectancy (palliative care ...)
             compromising his participation in the study at the discretion of the investigator;

          -  Patient benefiting from a safeguard of justice.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>75 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Bertrand CARIOU, Pr</last_name>
    <role>Principal Investigator</role>
    <affiliation>CHU de Nantes</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Bertrand CARIOU, Pr</last_name>
    <email>bertrand.cariou@chu-nantes.fr</email>
  </overall_contact>
  <location>
    <facility>
      <name>CHU de Nantes</name>
      <address>
        <city>Nantes</city>
        <state>Loire Atlantique</state>
        <zip>44000</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Bertrand CARIOU, Pr</last_name>
    </contact>
    <investigator>
      <last_name>Bertrand CARIOU, Pr</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Laure DE DECKER, Pr</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>CH d'Ancenis</name>
      <address>
        <city>Ancenis</city>
        <zip>44150</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <investigator>
      <last_name>Xavier ROUTON, Dr</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Pascale MAHOT-MOREAU, Dr</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>CHU d'Angers</name>
      <address>
        <city>Angers</city>
        <zip>49100</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <investigator>
      <last_name>Cédric ANWEILLER, Pr</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Séverine DUBOIS, Dr</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hôpital Sud Francilien</name>
      <address>
        <city>Corbeil-Essonnes</city>
        <zip>91106</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <investigator>
      <last_name>Nathalie CERVANTES, Dr</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Alfred PENFORNIS, Pr</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>CHU de Poitiers</name>
      <address>
        <city>Poitiers</city>
        <zip>86021</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <investigator>
      <last_name>Marc PACCALIN, Pr</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Samy HADJADJ, Pr</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Centre Hospitalier de Saint Nazaire</name>
      <address>
        <city>Saint Nazaire</city>
        <zip>44600</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <investigator>
      <last_name>Sylvie HILY, Dr</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>December 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>January 9, 2017</study_first_submitted>
  <study_first_submitted_qc>January 11, 2017</study_first_submitted_qc>
  <study_first_posted type="Estimate">January 13, 2017</study_first_posted>
  <last_update_submitted>December 22, 2017</last_update_submitted>
  <last_update_submitted_qc>December 22, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">December 27, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Type 2 Diabetes</keyword>
  <keyword>Hypoglycemia</keyword>
  <keyword>Elderly</keyword>
  <keyword>Insulinotherapy</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Diabetes Mellitus</mesh_term>
    <mesh_term>Diabetes Mellitus, Type 2</mesh_term>
    <mesh_term>Hypoglycemia</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

